ArticleClinical journal of gastroenterology2024

Sustained clinical and histopathological remission in a patient with eosinophilic esophagitis and type-2 comorbidities at 18 months after discontinuation of dupilumab.

Víctor González-Uribe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.